130 related articles for article (PubMed ID: 15048705)
1. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
Chen L; Jondal M
Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
[TBL] [Abstract][Full Text] [Related]
2. Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC.
Chen L; Jondal M
Mol Immunol; 2008 Nov; 46(1):158-65. PubMed ID: 18723224
[TBL] [Abstract][Full Text] [Related]
3. Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides.
Chen L; Jondal M
Scand J Immunol; 2004 Jun; 59(6):545-52. PubMed ID: 15182249
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
5. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
6. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen Z; Reznikoff G; Dranoff G; Rock KL
J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
[TBL] [Abstract][Full Text] [Related]
8. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
Harding CV; Song R
J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
[TBL] [Abstract][Full Text] [Related]
9. Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC.
Chen L; Fredholm BB; Jondal M
Mol Immunol; 2008 Apr; 45(8):2247-54. PubMed ID: 18178251
[TBL] [Abstract][Full Text] [Related]
10. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
11. CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells.
Bevaart L; Van Ojik HH; Sun AW; Sulahian TH; Leusen JH; Weiner GJ; Van De Winkel JG; Van Vugt MJ
Int Immunol; 2004 Aug; 16(8):1091-8. PubMed ID: 15192052
[TBL] [Abstract][Full Text] [Related]
12. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
13. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
14. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
[TBL] [Abstract][Full Text] [Related]
16. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells.
Han S; Song Y; Lee YH; Lee YR; Lee CK; Cho K; Kim K
Cytokine; 2005 Dec; 32(5):187-93. PubMed ID: 16303313
[TBL] [Abstract][Full Text] [Related]
18. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
19. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells.
Shakushiro K; Yamasaki Y; Nishikawa M; Takakura Y
Immunology; 2004 Jun; 112(2):211-8. PubMed ID: 15147564
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
